ArticleInternational journal of molecular sciences2024

FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.

Kengo Takeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.